Factor Viia

Download PDF

Recent Publications on Factor Viia:
Thromboelastography-Guided Recombinant Factor VIIa Administration in a Patient with Refractory Autoimmune Idiopathic Thrombocytopenia. Autoimmune idiopathic thrombocytopenia poses a significant challenge for...	18th July, 2008	Department of Anesthesia, Royal Free Hospital, Pond Street, London NW3	Anesth Analg. 2008 Aug;107(2):402-5. DOI Direct Link
Thrombelastography-Guided Factor VIIa Therapy in a Surgical Patient with Severe Hemophilia and Factor VIII Inhibitor. A patient with hemophilia and factor VIII inhibitors required urgent...	18th July, 2008	Department of Anesthesiology, University of Texas Health Science Center,	Anesth Analg. 2008 Aug;107(2):398-401. DOI Direct Link
Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. BACKGROUND: The current wars in Iraq and Afghanistan have resulted in the...	18th July, 2008	Madigan Army Medical	Crit Care Med. 2008 Jul;36(7 Suppl):S267-74. DOI Direct Link
Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophilia. Recombinant activated factor VII (rFVIIa) appears to be safe when used for...	17th July, 2008	Department of Pediatrics, Aflac Cancer Center, and Blood Disorders	Semin Hematol. 2008 Apr;45(2 Suppl 1):S3-6. DOI Direct Link
Factor VIIa interaction with tissue factor and endothelial cell protein C receptor on cell surfaces. Factor VIIa (FVIIa) is the enzyme that triggers activation of the clotting...	17th July, 2008	Biomedical Research, The University of Texas Health Center at Tyler,	Semin Hematol. 2008 Apr;45(2 Suppl 1):S21-4. DOI Direct Link
→View more research publications.

BioNews Results for Factor Viia:
GTC Biotherapeutics Receives NASDAQ Notice of Non-Compliance	SmartBrief:  Jul 18 2008 9:38PM Matching: factor viia
Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based	CHEST:  Jul 16 2008 2:37AM Matching: factor viia
Bayer Buys Maxygen Hematology Drugs	FDA News:  Jul 10 2008 9:38PM Matching: factor viia
Coagulation Gene Therapy - Researchers from King's College London describe findings in coagulation gene therap	NewsRX:  Jul 8 2008 12:14AM Matching: factor viia
GTC Biotherapeutics to Webcast Corporate Presentation at the Collins Stewart Fourth Annual Growth Conference	DiGiTAL50:  Jul 8 2008 7:04AM Matching: factor viia
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Factor Viia Clinical Trials:
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage	Spontaneous Intracerebral Haemorrhage

Factor Viia Patents:
US Patent No.	Title
7358055	Diagnostic markers of acute coronary syndrome and methods of use thereof
7371543	Factor VII or VIIa-like molecules
7371722	Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
7371729	Boronic acid salts useful in parenteral formulations
7371743	Carboxylic acid amides, the preparation thereof and their use as medicaments
→View more patents.

Companies working in the area of Factor Viia from Bioportfolio's Biocorporate database :
Company Name
Nuvelo Nuvelo, Inc. is a publicly traded biopharmaceutical company dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute... www.nuvelo.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Factor Viia scientists - we have details of around 239 individuals working on Factor Viia .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.